United States Olmesartan Market Report 2017

February 2017 | 117 pages | ID: U1FA91966EFEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Olmesartan

Revenue, means the sales value of Olmesartan

This report studies sales (consumption) of Olmesartan in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Daiichi Sankyo Company
• Zydus Cadila
• Ranbaxy Laboratories Limited

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Olmesartan in each application, can be divided into

• Application 1
• Application 2

Contents

United States Olmesartan Market Report 2017

1 OLMESARTAN OVERVIEW

1.1 Product Overview and Scope of Olmesartan
1.2 Classification of Olmesartan
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Olmesartan
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Olmesartan (2012-2022)
  1.4.1 United States Olmesartan Sales and Growth Rate (2012-2022)
  1.4.2 United States Olmesartan Revenue and Growth Rate (2012-2022)

2 UNITED STATES OLMESARTAN COMPETITION BY MANUFACTURERS

2.1 United States Olmesartan Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Olmesartan Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Olmesartan Average Price by Manufactures (2015 and 2016)
2.4 Olmesartan Market Competitive Situation and Trends
  2.4.1 Olmesartan Market Concentration Rate
  2.4.2 Olmesartan Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES OLMESARTAN SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Olmesartan Sales and Market Share by States (2012-2017)
3.2 United States Olmesartan Revenue and Market Share by States (2012-2017)
3.3 United States Olmesartan Price by States (2012-2017)

4 UNITED STATES OLMESARTAN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Olmesartan Sales and Market Share by Type (2012-2017)
4.2 United States Olmesartan Revenue and Market Share by Type (2012-2017)
4.3 United States Olmesartan Price by Type (2012-2017)
4.4 United States Olmesartan Sales Growth Rate by Type (2012-2017)

5 UNITED STATES OLMESARTAN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Olmesartan Sales and Market Share by Application (2012-2017)
5.2 United States Olmesartan Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES OLMESARTAN MANUFACTURERS PROFILES/ANALYSIS

6.1 Daiichi Sankyo Company
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Olmesartan Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Daiichi Sankyo Company Olmesartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Zydus Cadila
  6.2.2 Olmesartan Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Zydus Cadila Olmesartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Ranbaxy Laboratories Limited
  6.3.2 Olmesartan Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Ranbaxy Laboratories Limited Olmesartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview

7 OLMESARTAN MANUFACTURING COST ANALYSIS

7.1 Olmesartan Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Olmesartan

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Olmesartan Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Olmesartan Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OLMESARTAN MARKET FORECAST (2017-2022)

11.1 United States Olmesartan Sales, Revenue Forecast (2017-2022)
11.2 United States Olmesartan Sales Forecast by Type (2017-2022)
11.3 United States Olmesartan Sales Forecast by Application (2017-2022)
11.4 Olmesartan Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Olmesartan
Table Classification of Olmesartan
Figure United States Sales Market Share of Olmesartan by Type in 2015
Table Application of Olmesartan
Figure United States Sales Market Share of Olmesartan by Application in 2015
Figure United States Olmesartan Sales and Growth Rate (2012-2022)
Figure United States Olmesartan Revenue and Growth Rate (2012-2022)
Table United States Olmesartan Sales of Key Manufacturers (2015 and 2016)
Table United States Olmesartan Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Olmesartan Sales Share by Manufacturers
Figure 2016 Olmesartan Sales Share by Manufacturers
Table United States Olmesartan Revenue by Manufacturers (2015 and 2016)
Table United States Olmesartan Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Olmesartan Revenue Share by Manufacturers
Table 2016 United States Olmesartan Revenue Share by Manufacturers
Table United States Market Olmesartan Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Olmesartan Average Price of Key Manufacturers in 2015
Figure Olmesartan Market Share of Top 3 Manufacturers
Figure Olmesartan Market Share of Top 5 Manufacturers
Table United States Olmesartan Sales by States (2012-2017)
Table United States Olmesartan Sales Share by States (2012-2017)
Figure United States Olmesartan Sales Market Share by States in 2015
Table United States Olmesartan Revenue and Market Share by States (2012-2017)
Table United States Olmesartan Revenue Share by States (2012-2017)
Figure Revenue Market Share of Olmesartan by States (2012-2017)
Table United States Olmesartan Price by States (2012-2017)
Table United States Olmesartan Sales by Type (2012-2017)
Table United States Olmesartan Sales Share by Type (2012-2017)
Figure United States Olmesartan Sales Market Share by Type in 2015
Table United States Olmesartan Revenue and Market Share by Type (2012-2017)
Table United States Olmesartan Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Olmesartan by Type (2012-2017)
Table United States Olmesartan Price by Type (2012-2017)
Figure United States Olmesartan Sales Growth Rate by Type (2012-2017)
Table United States Olmesartan Sales by Application (2012-2017)
Table United States Olmesartan Sales Market Share by Application (2012-2017)
Figure United States Olmesartan Sales Market Share by Application in 2015
Table United States Olmesartan Sales Growth Rate by Application (2012-2017)
Figure United States Olmesartan Sales Growth Rate by Application (2012-2017)
Table Daiichi Sankyo Company Basic Information List
Table Daiichi Sankyo Company Olmesartan Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Daiichi Sankyo Company Olmesartan Sales Market Share (2012-2017)
Table Zydus Cadila Basic Information List
Table Zydus Cadila Olmesartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Zydus Cadila Olmesartan Sales Market Share (2012-2017)
Table Ranbaxy Laboratories Limited Basic Information List
Table Ranbaxy Laboratories Limited Olmesartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ranbaxy Laboratories Limited Olmesartan Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Olmesartan
Figure Manufacturing Process Analysis of Olmesartan
Figure Olmesartan Industrial Chain Analysis
Table Raw Materials Sources of Olmesartan Major Manufacturers in 2015
Table Major Buyers of Olmesartan
Table Distributors/Traders List
Figure United States Olmesartan Production and Growth Rate Forecast (2017-2022)
Figure United States Olmesartan Revenue and Growth Rate Forecast (2017-2022)
Table United States Olmesartan Production Forecast by Type (2017-2022)
Table United States Olmesartan Consumption Forecast by Application (2017-2022)
Table United States Olmesartan Sales Forecast by States (2017-2022)
Table United States Olmesartan Sales Share Forecast by States (2017-2022)